An NCI-designated Comprehensive Cancer Center

Myeloma and Multiple Myeloma

Myeloma is not a common cancer, accounting for less than 1 percent of new cancer cases and 10 percent of all blood and bone marrow cancers. Myeloma develops when plasma cells - infection-fighting blood cells in the immune system - become abnormal and grow and divide uncontrollably to become tumors.

The Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope is known internationally for its research breakthroughs and clinical treatments. We treat the full spectrum of the disease - whether you are in the early precursor stage, are newly diagnosed, have cancer that has returned or have failed other therapies.

Request a consultation

City of Hope’s world-renowned myeloma cancer care team uses the latest technology and innovation to treat cancer while providing compassionate care. Call 800-826-4673 or request an appointment online. Visit Making Your First Appointment for more information.

Our Expertise

City of Hope is internationally recognized for its research and breakthrough treatments, has been named one of America’s top cancer hospitals by U.S. News & World Report for over a decade running and is a National Cancer Institute-designated comprehensive cancer center.

Highlights of our myeloma program include:

  • Promising new therapies as part of our clinical trials program, including innovations in gene, CAR T cell and antibody therapy — to boost the immune system response to cancer
  • Collaboration with the Multiple Myeloma Research Consortium, providing quick access to the best therapies, including the newest, most innovative clinical trials
  • A pioneering blood and bone marrow program, one of the largest transplant centers in the U.S., which consistently produces some of the best outcomes — and whose innovative approaches include combining transplantation with new therapies
  • Virtually unrivaled expertise with immunotherapy — including involvement in pivotal early trials for drugs now a part of myeloma therapy worldwide such as daratumumab, the first monoclonal antibody approved for the treatment of myeloma
  • Understanding of unique issues facing older myeloma patients, including tailoring treatments to make them more effective and reducing side effects using computer models to predict toxicity
  • Outpatient bone marrow transplantation, provided by highly trained, experienced transplant nurses
  • Genetic testing and customized drug therapy tailored to the molecular profile of specific myeloma types
  • Survivorship clinics that provide support and monitoring to patients throughout the course of the disease

Comprehensive care

City of Hope is one of only a few dozen centers in the country that treat myeloma using a comprehensive approach — by a multidisciplinary team whose sole focus is treating this type of cancer. Your care includes regular interaction and input from a team that includes hematologists, oncologists, radiologists and pathologists, along with nurses, social workers and specially trained support staff. This team brings together deep experience and diverse perspectives — shaped by seeing and treating myeloma every day — to arrive at the ideal treatment for every patient.

News & Breakthroughs


Help us turn innovative ideas into powerful new treatments
$ Other